STOCK TITAN

[Form 4] Vita Coco Company, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Vita Coco Company, Inc. Chief Commercial Officer Charles van Es reported an open-market sale of 2,000 shares of common stock on April 1, 2026 at $48.67 per share. The sale was effected under a Rule 10b5-1 trading plan.

Following this sale, he directly owns 77,691 shares of common stock. He also holds multiple non-qualified stock options to buy Vita Coco common stock, with exercise prices ranging from $10.178 to $33.36 per share and expiration dates between 2030 and 2035.

Positive

  • None.

Negative

  • None.
Insider van Es Charles
Role Chief Commercial Officer
Sold 2,000 shs ($97K)
Type Security Shares Price Value
Sale Common Stock 2,000 $48.67 $97K
holding Non-Qualified Stock Option (Right to Buy) -- -- --
holding Non-Qualified Stock Option (Right to Buy) -- -- --
holding Non-Qualified Stock Option (Right to Buy) -- -- --
holding Non-Qualified Stock Option (Right to Buy) -- -- --
holding Non-Qualified Stock Option (Right to Buy) -- -- --
holding Non-Qualified Stock Option (Right to Buy) -- -- --
holding Non-Qualified Stock Option (Right to Buy) -- -- --
holding Non-Qualified Stock Option (Right to Buy) -- -- --
Holdings After Transaction: Common Stock — 77,691 shares (Direct); Non-Qualified Stock Option (Right to Buy) — 53,750 shares (Direct)
Footnotes (1)
  1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. The stock option is fully vested and currently exercisable. The stock option vests in four equal annual installments beginning on November 27, 2022. The stock option vests in three equal annual installments beginning on August 15, 2025. The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026. The stock options vest in four annual equal installments beginning on March 10, 2024. The stock option vests in four equal annual installments beginning on March 4, 2025. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
Shares sold 2,000 shares Open-market sale of common stock on April 1, 2026
Sale price $48.67 per share Price for 2,000 Vita Coco common shares sold
Common shares held after sale 77,691 shares Direct ownership of Vita Coco common stock post-transaction
Option exercise price $10.178 per share Non-qualified stock options expiring in 2030 and 2031
Option exercise price $15.00 per share Non-qualified stock options expiring on October 21, 2031
Highest option exercise price $33.36 per share Non-qualified stock options expiring on March 4, 2035
Vested performance option tranche 14,025 shares Performance-based option vested on February 20, 2026
Rule 10b5-1 trading plan financial
"The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Non-Qualified Stock Option (Right to Buy) financial
"security_title: Non-Qualified Stock Option (Right to Buy)"
performance conditions financial
"The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s)"
vest financial
"The stock option vests in four equal annual installments beginning on November 27, 2022."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
expiration date financial
"expiration_date: 2035-03-04T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
van Es Charles

(Last)(First)(Middle)
111 5TH AVENUE
2ND FLOOR

(Street)
NEW YORK NEW YORK 10003

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Commercial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/01/2026S(1)2,000D$48.6777,691D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-Qualified Stock Option (Right to Buy)$10.178 (2)02/10/2030Common Stock53,75053,750D
Non-Qualified Stock Option (Right to Buy)$10.178 (2)01/11/2031Common Stock27,30027,300D
Non-Qualified Stock Option (Right to Buy)$15 (3)10/21/2031Common Stock58,04358,043D
Non-Qualified Stock Option (Right to Buy)$15.36 (4)08/15/2032Common Stock42,98042,980D
Non-Qualified Stock Option (Right to Buy)$16.91 (5)03/10/2033Common Stock14,02514,025D
Non-Qualified Stock Option (Right to Buy)$16.91 (6)03/10/2033Common Stock14,20514,205D
Non-Qualified Stock Option (Right to Buy)$26.18 (7)03/04/2034Common Stock8,7468,746D
Non-Qualified Stock Option (Right to Buy)$33.36 (8)03/04/2035Common Stock13,21813,218D
Explanation of Responses:
1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
2. The stock option is fully vested and currently exercisable.
3. The stock option vests in four equal annual installments beginning on November 27, 2022.
4. The stock option vests in three equal annual installments beginning on August 15, 2025.
5. The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.
6. The stock options vest in four annual equal installments beginning on March 10, 2024.
7. The stock option vests in four equal annual installments beginning on March 4, 2025.
8. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
/s/ Alison Klein, attorney-in-fact for Charles van Es04/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)